GBA mutations in Parkinson disease: earlier death but similar neuropathological features
European Journal of Neurology2017Vol. 24(11), pp. 1363–1368
Citations Over TimeTop 10% of 2017 papers
Charles H. Adler, Thomas G. Beach, H. A. Shill, John N. Caviness, Erika Driver‐Dunckley, Marwan N. Sabbagh, Amit Patel, Lucia I. Sue, Geidy E. Serrano, Sandra A. Jacobson, Kathryn Davis, Christine M. Belden, Brittany N. Dugger, Sara A. Paciga, Ashley R. Winslow, Warren D. Hirst, Joseph G. Hentz
Abstract
In longitudinally assessed, autopsied PD cases, those with GBA mutations had a younger age at death but there was no evidence for clinical or neuropathological differences compared to cases without GBA mutations. Due to the small GBA group size, small differences cannot be excluded.
Related Papers
- → Neuropathology of type 2 diabetes: a short review on insulin-related mechanisms(2014)13 cited
- → The Current Status of Neuropathology in the Federal Republic of Germany 1979(1979)2 cited
- → Perspectives in neuropathology(1961)2 cited
- → P2–206: Cerebral amyloid angiopathy and its co‐occurrence with Alzheimer's disease in the National Alzheimer's Coordinating Center Neuropathology data set(2013)
- International courses Neuropathology(2020)